Rubric Capital Management LP

13F Holdings History for HERON THERAPEUTICS, INC. /DE/ - Common Stock (HRTX)

Symbol: HRTX on Nasdaq
Investment type: Equity / Common Stock
Latest Disclosed Ownership: 30M shares
Security Ownership: 15.9%

Shares, Excluding Options vs Price

Value, Excluding Options

Rubric Capital Management LP ownership in HERON THERAPEUTICS, INC. /DE/ Common Stock (HRTX)

2025-10-17 - Rubric Capital Management LP has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 30M shares of HERON THERAPEUTICS, INC. /DE/ Common Stock (HRTX). This represents 15.9% percent ownership of the company. In their previous filing dated 2025-08-12, Rubric Capital Management LP had reported owning 29.1M shares, indicating an increase of 3.25% percent.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
Rubric Capital Management LP	15.9%	-8.89%	$37.9M	30M	+946,100	+3.25%	$1.26	13D/A	10/15/2025	17 Oct 2025 18:02:46
Rubric Capital Management LP	17.5%		$60.2M	29.1M			$2.07	13D/A	8/8/2025	12 Aug 2025 18:00:55

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
9/30/2025	0.49%	+0.04%	$36.7M	29.1M	+2,387,225	+8.94%	$1.26	Q3 2025
6/30/2025	0.89%		$55.3M	26.7M			$2.07	Q2 2025
3/31/2025	1.05%		$58.8M	26.7M			$2.20	Q1 2025
12/31/2024	0.74%		$40.9M	26.7M			$1.53	Q4 2024
9/30/2024	0.87%		$53.2M	26.7M			$1.99	Q3 2024
6/30/2024	2.47%		$93.5M	26.7M			$3.50	Q2 2024
3/31/2024	2.19%		$74M	26.7M			$2.77	Q1 2024
12/31/2023	0.94%		$45.4M	26.7M			$1.70	Q4 2023
9/30/2023	1.03%	+0.58%	$27.5M	26.7M	+14,963,503	+127%	$1.03	Q3 2023
6/30/2023	0.58%		$13.6M	11.8M			$1.16	Q2 2023
3/31/2023	0.46%		$17.7M	11.8M			$1.51	Q1 2023
12/31/2022	1.28%	+1.01%	$29.4M	11.8M	+9,233,672	+367%	$2.50	Q4 2022
9/30/2022	0.53%	+0.53%	$10.6M	2.52M	+2,516,328	NEW	$4.22	Q3 2022
6/30/2019		-3.42%	$0	0	-1,500,000	-100%		Q2 2019
3/31/2019	3.42%	-2.94%	$36.7M	1.5M	-1,287,592	-46.2%	$24.44	Q1 2019
12/31/2018	8.95%	+2.66%	$72.3M	2.79M	+828,742	+42.3%	$25.94	Q4 2018
9/30/2018	6.55%	+2.74%	$62M	1.96M	+818,603	+71.8%	$31.65	Q3 2018
6/30/2018	4.35%	-1.41%	$44.3M	1.14M	-369,761	-24.5%	$38.85	Q2 2018
3/31/2018	3.88%	-1.77%	$41.7M	1.51M	-687,304	-31.3%	$27.60	Q1 2018
12/31/2017	4.91%	+0.66%	$39.8M	2.2M	+297,312	+15.6%	$18.10	Q4 2017
9/30/2017	2.82%	+0.3%	$30.7M	1.9M	+200,000	+11.8%	$16.15	Q3 2017
6/30/2017	4.85%	+0.29%	$23.5M	1.7M	+100,000	+6.25%	$13.85	Q2 2017
3/31/2017	6.99%	+4.58%	$24M	1.6M	+1,050,000	+191%	$15.00	Q1 2017
12/31/2016	2.48%		$7.21M	550K			$13.10	Q4 2016

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.